KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Long-Term Investments (2017 - 2025)

Historic Long-Term Investments for Moderna (MRNA) over the last 9 years, with Q3 2025 value amounting to $2.1 billion.

  • Moderna's Long-Term Investments fell 822.27% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year decrease of 822.27%. This contributed to the annual value of $2.5 billion for FY2024, which is 4667.52% down from last year.
  • Latest data reveals that Moderna reported Long-Term Investments of $2.1 billion as of Q3 2025, which was down 822.27% from $2.4 billion recorded in Q2 2025.
  • Moderna's 5-year Long-Term Investments high stood at $10.2 billion for Q2 2022, and its period low was $468.0 million during Q1 2021.
  • Over the past 5 years, Moderna's median Long-Term Investments value was $4.7 billion (recorded in 2023), while the average stood at $5.0 billion.
  • Per our database at Business Quant, Moderna's Long-Term Investments surged by 185961.54% in 2022 and then crashed by 6190.01% in 2024.
  • Over the past 5 years, Moderna's Long-Term Investments (Quarter) stood at $6.8 billion in 2021, then increased by 21.55% to $8.3 billion in 2022, then tumbled by 43.77% to $4.7 billion in 2023, then plummeted by 46.68% to $2.5 billion in 2024, then fell by 14.07% to $2.1 billion in 2025.
  • Its last three reported values are $2.1 billion in Q3 2025, $2.4 billion for Q2 2025, and $2.4 billion during Q1 2025.